CDK4 and prostate carcinoma: In MAT-LyLu cells, gossypol reduced the expression of cyclin D1, cyclin-dependent kinase 4 (CDK4), and phospho-retinoblastoma (p-Rb), which regulate the progression of the cell cycle in prostate cancer cells.